10 completed. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 10 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate Tofacitinib, Methotrexate - Scleroderma, Systemic | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 34 | 2024-12-21 | 2026-03-16 |
| Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Upfront autologous HSCT - Systemic Sclerosis, Systemic Scleroses, Diffuse | Phase 4 | Completed | UMC Utrecht | 60 | 2020-09-17 | 2026-03-24 |
| Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients Acetylsalicylic acid, Placebo oral capsule - Systemic Sclerosis | Phase 4 | Completed | Federal University of São Paulo | 70 | 2018-08-28 | 2021-12-01 |
| The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis bosentan - Scleroderma, Systemic | Phase 4 | Completed | University Medical Center Groningen | 20 | 2015-06-26 | 2018-12-13 |
| Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis Saccharomyces Boulardii Oral Tablet, Metronidazole - Systemic Sclerosis, Small Intestinal Bacterial Overgrowth | Phase 4 | Completed | Coordinación de Investigación en Salud, Mexico | 39 | 2015-06-01 | 2019-07-30 |
| Bosentan in Systemic Sclerosis Bosentan - Systemic Sclerosis, Digital Ulcers | Phase 4 | Completed | Actelion | 18 | 2011-03-31 | 2026-06-03 |
| A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis tadalafil and ambrisentan upfront combination therapy - Pulmonary Arterial Hypertension, Systemic Sclerosis | Phase 4 | Completed | Johns Hopkins University | 25 | 2010-01-01 | 2017-09-12 |
| Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan Ambrisentan - Systemic Sclerosis, Shortness of Breath | Phase 4 | Completed | University of California, Los Angeles | 12 | 2009-03-01 | 2020-11-02 |
| Pulmonary Artery Remodelling With Bosentan bosentan - Hypertension, Pulmonary | Phase 4 | Completed | Actelion | 11 | 2006-05-31 | 2026-06-03 |
| Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon Pletal - Raynaud's Disease | Phase 4 | Completed | Otsuka America Pharmaceutical | 75 | 2001-10-01 | 2005-07-19 |
Hypertension, Pulmonary (3) · Scleroderma, Diffuse (3) · Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Dyspnea (1) · Hypertension (1) · Mixed Connective Tissue Disease (1) · Pulmonary Arterial Hypertension (1) · Raynaud Disease (1) · Sclerosis (1) · digital ulcers (1)
Skin Diseases (10) · Skin and Connective Tissue Diseases (10) · Connective Tissue Diseases (8) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Hypertension (2) · Pathological Conditions, Signs and Symptoms (2) · Embolism and Thrombosis (1) · Immune System Diseases (1) · Livedoid Vasculopathy (1) · Pathologic Processes (1) · Peripheral Vascular Diseases (1)
Bosentan (3) · ambrisentan (2) · Aspirin (1) · Cilostazol (1) · Methotrexate (1) · Metronidazole (1) · Tadalafil (1) · tofacitinib (1)
Actelion (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Coordinación de Investigación en Salud, Mexico (1) · Federal University of São Paulo (1) · Johns Hopkins University (1) · Otsuka America Pharmaceutical (1) · UMC Utrecht (1) · University Medical Center Groningen (1) · University of California, Los Angeles (1)
Netherlands (3) · United States (3) · Australia (1) · Bangladesh (1) · Brazil (1) · Italy (1) · Mexico (1) · United Kingdom (1)
Andries J Smit, MDPhD (1) · Cristiane Kayser, PhD (1) · David Celermajer, Professor (1) · Dinesh Khanna, MD (1) · Jacob M van Laar, MD PhD (1) · Julia Spierings (1) · Md. Abu Shahin, FCPS, MD (1) · Paul Hassoun, MD (1) · Rajeev Saggar, MD (1)
PMID 22777623, PMID 26360334, PMID 29251556, PMID 31549334, PMID 33737437
P50HL084946 (1)